{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:18:52Z","timestamp":1781626732787,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02068-9","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:00:53Z","timestamp":1758877253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States"],"prefix":"10.1186","volume":"27","author":[{"given":"Hyuna","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Jatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"6","key":"2068_CR1","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, Jemal A, Siegel RL. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(6):477\u201395.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2068_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jamcollsurg.2019.01.018","volume":"228","author":"TO Oseni","year":"2019","unstructured":"Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women. J Am Coll Surg. 2019;228(6):932\u20139.","journal-title":"J Am Coll Surg"},{"issue":"20","key":"2068_CR3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"VL Ernster","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546\u201354.","journal-title":"J Natl Cancer Inst"},{"key":"2068_CR4","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-Based Mortality - SEER Research Plus Data, 8 Registries, Nov 2023 Sub (1975\u20132021) - Linked To County Attributes - Total U.S., 1969\u20132022 Counties. In., April 2024 edn: National Cancer Institute, DCCPS, Surveillance Research Program; 2024."},{"key":"2068_CR5","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-Based Mortality - SEER Research Plus Data, 12 Registries, Nov 2023 Sub (1992\u20132021) - Linked To County Attributes - Total U.S., 1969\u20132022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission."},{"key":"2068_CR6","unstructured":"Site Recode ICD-O-3\/WHO 2008 Definition [https:\/\/seer.cancer.gov\/siterecode\/icdo3_dwhoheme\/index.html]"},{"issue":"12","key":"2068_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","volume":"47","author":"KC Chu","year":"1994","unstructured":"Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol. 1994;47(12):1451\u201361.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2068_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0962280206070621","volume":"15","author":"RC Tiwari","year":"2006","unstructured":"Tiwari RC, Clegg LX. Z Z: Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547\u201369.","journal-title":"Stat Methods Med Res"},{"issue":"9","key":"2068_CR9","doi-asserted-by":"publisher","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","volume":"3","author":"V Giannakeas","year":"2020","unstructured":"Giannakeas V, Sopik V, Narod SA. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer. JAMA Netw Open. 2020;3(9):e2017124.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2068_CR10","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1(7):888\u201396.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2068_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","volume":"169","author":"SA Narod","year":"2018","unstructured":"Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat. 2018;169(1):9\u201323.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2068_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.2024.26698","volume":"333","author":"ES Hwang","year":"2025","unstructured":"Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, et al. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA. 2025;333(11):972\u201380.","journal-title":"JAMA"},{"issue":"2","key":"2068_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10549-004-1483-9","volume":"88","author":"WF Anderson","year":"2004","unstructured":"Anderson WF, Chu KC, Devesa SS. Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications. Breast Cancer Res Treat. 2004;88(2):149\u201359.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2068_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-014-3151-z","volume":"148","author":"Y Liu","year":"2014","unstructured":"Liu Y, Colditz GA, Gehlert S, Goodman M. Racial disparities in risk of second breast tumors after ductal carcinoma in situ. Breast Cancer Res Treat. 2014;148(1):163\u201373.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2068_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10549-016-4030-6","volume":"160","author":"CC Madubata","year":"2016","unstructured":"Madubata CC, Liu Y, Goodman MS, Yun S, Yu J, Lian M, Colditz GA. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race. Breast Cancer Res Treat. 2016;160(3):563\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2068_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13058-024-01885-8","volume":"26","author":"SH Strand","year":"2024","unstructured":"Strand SH, Houlahan KE, Branch V, Lynch T, Rivero-Guitierrez B, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, et al. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. Breast Cancer Res. 2024;26(1):127.","journal-title":"Breast Cancer Res"},{"issue":"18","key":"2068_CR17","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1002\/cncr.32200","volume":"125","author":"Y Liu","year":"2019","unstructured":"Liu Y, West R, Weber JD, Colditz GA. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ. Cancer. 2019;125(18):3225\u201333.","journal-title":"Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:00:56Z","timestamp":1758877256000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02068-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used de-identified publicly available data, which is considered non-human participants research under the Common Rule (US federal regulation 45 CFR \u00a746); thus, institutional review board approval and informed consent were not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}